Rare Disease-Orphan Drug Institutional Key Account Manager.Hospital and Center of Excellence leadership responsibilities. Account management. Annual Sales Trainer (ATS Cohort 004/003)Emerging Leadership Professional DevelopmentPerformance 2023 UCB Pinnacle National Award

Rare Disease-Orphan Drug Institutional Key Account Manager within start-up organization.Hospital and Center of Excellence leadership and responsibilityPerformance: 2021 Pinnacle Commercial Excellence National Award 2020 Pinnacle Commercial National Launch Excellence AwardCross-functional collaborations: National Sales Training field trainerSales and Marketing Advisory Committee (SMAC)Hospital account management teamKey opinion leadership developmentNational Distribution Task ForceMarketing Facebook Live cross-functional collaboration and KOL Championing Business leveling strategic planning cross-collaboration Virtual presentation and execution project ZOOM Buisness development and execution with cross functional peers

Start-up organization with orphan drug rare disease launch Pediatric and Adult Rare Disease-Institutional Account Management with severe diseases associated with genetic mutations with Hospital in-patient and outpatient care and administration: Dravet Syndrome (DS: Type 1 Voltage-Gated Sodium Channel; Primary SCN1-A metabolism) Lennox-Gastaut (LGS: Chromodomain-helicase DNA binding protein 2; Primary CHD2) Performance: 2019 Champions Club runner-up (Top 5/66 National achievement) 2018 Product Launch Sales Leadership Mover and Shaker AwardCenter of Excellence Account Management: Level 4 Institutional Accounts: CHLA, USC, LAC, Rancho Los Amigos, Olive View Medical Center (UCLA), Harbor UCLA, San Antonio Medical Center, Kern Medical Center, and Loma Linda Medical Center Responsible for fascinating and coordinating institutional Specialty Pharmacy processes connected with Cardinal Health distribution (additionally responsible for negotiating the 340B/MOU processes and courtesy transfer collaboration with McKesson accounts)Patient Advocacy: Epilepsy Foundation, Child Neurology Foundation, Dravet Foundation, LGS Foundation, Brain Recovery Project, Batten Disease Project 2019 Specialty pharmacy and Distribution work group (in-patient and outpatient services)

Autoimmune and Rare Disease Specialist (Acthar/ACTH/Orphan Drug Biologic injectable (subcutaneous and intramuscular) Neurology, Neuro-Ophthalmology, Pediatric Neurology: Multiple Sclerosis (MS), Optic Neuritis (ON), Epileptic Spasm/Infantile Spasms (IS), Neuromuscular and Rheumatology: Dermatomyositis-Polymyositis (DM/PM), Specialty Hub/Buy and bill reimbursement; complex pulling-through one patient at a time and working closely with reimbursement managers for drug approval.PerformanceRelaunch: Transforming a Tier 5 geography into a top-performing Tier 1 book of business with performance consistently exceeding quarterly over quarter vial goals (Device type sales) Institutional Centers of Excellence Accounts: USC, UCLA, CHLA, Miller's Children's Hospital, Sansum Hospital, Paso Robles, Kern County, and Ventura Medical Center, Regal-Lakeside Medical group, White Memorial, Cedars Pts. Advocacy: NORD, RARE Connect, Epilepsy Foundation (IS-West Syndrome), Child Neurology Foundation, NMSS, MSAA, MS News and Views, MS Cure FundNeuromuscular Movement Disorders: Movement Disorder Foundation, Neuromuscular Foundation, American Brain Foundation 2018 NSM Planning Committee2017-2018 Marketing Project-Product Messaging/Branding collaborating creative team, product management, training, marketing, leadership, patient and reimbursement services, and medical team 2017 Kaiser Permanente Lead2017 STEM Project-Accelerating Marketing Performance Project 2017, 2016, 2015, Marketing/Patient Advocacy Campaign 2017 Field Marketing Board (FAB) with national brand marketing team 2016 Clinical Advisory Board (CAB)2015/2016 Cross-cultural Marketing Campaigns: Hispanic and African American 2015 National Key Opinion Leader Broadcast with a national Marketing team project2017 IS Brand Marketing/Sales Leadership/Management BoardKOL Dev.Strategic Round tables/Advisory Boards w/ MDM Team 2017 Reimbursement and Area Regional Management (ARM) Managed Care pull-through

Regional Key Account Specialist/ESC: CA, NV, AZ, and HINeurology and Diagnostic Imaging (2007-2015)Executive Sales Consultant Specialized Medicine September 2005-2006 Kaiser Account Specialist 2001-2005 (Cardiology, Hematology/Oncology, Neurology)SR. Sales Consultant Specialized Therapeutics 2000-2001 (Card, Hem, Neuro)Professional Sales Consultant Therapeutics (Card/Neuro) 1998-2000Executive Sales Consultant Mentor Western AreaPerformance:2013, 2012 Presidents Circle of Excellence2009 Runner-Up President Circle of Excellence (KAS)2001, 2003, 2006 Sales Leadership Awards B2B Institutional Accounts: Academic Medical Centers, VA/DOD Hospitals, Community Hospitals, and specialty clinicsBiologic injectable and Intravenous Product launch strategic planning Leukine (Sargramostim-Gastroenterology-Crohn's) hematopoietic growth factor that stimulates neutrophils, monocyte/macrophages, and dendritic cellsCampath/Lemtrada ( Alemtuzumab/MS CD52) CARE 1 and CARE 2 Medical Team Collaborations/Recruitment (Phase 3) Betaseron-START and COMFORT Clinical Study Collaboration and Recruitment (Ph 4)Marketing/Medical Field Ad Board Committees Managed Markets/National Development: Managed-Care Archetype Managed Modeling/(HERO data)IT projects: VEEVA (SFA Salesforce), Regional/National Webinars with KOLs National/Global Congresses representation (ANA, AHA, ASH, AAN, CMSC, ACCTRIMS, and Critical Care Symposiums)National Patient Advocacy Events: Identification, Coordination, and ExecutionKey Opinion Leader Development: coordination, identification, engagement, and training (20 new KOL advocates across multiple diseases states: Neurology, Neuro-ophthalmology, Cardiology, Hematology/Oncology, and Pharmacy)National Sales Meeting (NSM) project